Abstract | BACKGROUND: Targeting antigens to dendritic cells (DCs) via nanoparticles is a powerful strategy which improves the efficacy of ex vivo antigen-pulsed DC vaccines. METHODS: In this study, liposomes were first decorated with gp10025-33 self-antigen and then characterized. Then, DCs were pulsed ex vivo with liposomal gp100 and injected subcutaneously in mice bearing B16F10 established melanoma tumors in combination with anti-PD-1 therapy. RESULTS: Treatment with liposomal pulsed DC vaccine elicited the strongest anticancer immunity and enhanced intratumoral immune responses based on infiltration of gp100-specific CD4+ and CD8+ T cells to the tumor leading to significant tumor growth regression and prolonged survival rate. Treatment with liposomal pulsed DC vaccine also markedly enhanced specific cytotoxic T lymphocytes (CTL) responses with a significant higher titer of IFN-γ in the spleen. Moreover, a significant increase of PD-1 expressing CD8+ tumor infiltrating lymphocytes (TILs) was detected in tumors. CONCLUSION: Our results demonstrate an optimum dose of liposomal gp100 significantly increases the efficacy of anti-PD-1 therapy in mice and might be an effective strategy to overcome resistance to anti-PD-1 therapy.
|
Authors | Mona Yazdani, Zahra Gholizadeh, Amin Reza Nikpoor, Mahdi Hatamipour, Behrang Alani, Hossein Nikzad, Nema Mohamadian Roshan, Javad Verdi, Mahmoud Reza Jaafari, Mahdi Noureddini, Ali Badiee |
Journal | Vaccine
(Vaccine)
Vol. 38
Issue 35
Pg. 5665-5677
(07 31 2020)
ISSN: 1873-2518 [Electronic] Netherlands |
PMID | 32653275
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2020 Elsevier Ltd. All rights reserved. |
Chemical References |
- Cancer Vaccines
- Liposomes
- Membrane Glycoproteins
- Neoplasm Proteins
- Peptides
- gp100 Melanoma Antigen
|
Topics |
- Animals
- Cancer Vaccines
- Dendritic Cells
- Liposomes
- Melanoma
(therapy)
- Membrane Glycoproteins
- Mice
- Neoplasm Proteins
- Peptides
- T-Lymphocytes, Cytotoxic
- Vaccination
- gp100 Melanoma Antigen
|